Respiratory

Latest News

Zopapogene imadenovec, a non-replicating adenoviral vector-based immunotherapy, expresses a fusion antigen made up of selected regions of human papillomavirus (HPV) types 6 and 11 proteins. | Image Credit: aznan - stock.adobe.com
FDA Approves Zopapogene Imadenovec for Recurrent Respiratory Papillomatosis

August 19th 2025

The FDA approved zopapogene imadenovec, the first therapy for recurrent respiratory papillomatosis, providing an option beyond repeated surgeries to manage the rare condition.

The results showed a significant improvement in patient-reported symptoms at the 12-month follow-up. | Image credit: doucefleur - stock.adobe.com
Biologics Relieve Ear-Related Symptoms Linked With Asthma, CRwNP

August 16th 2025

Obstructive sleep apnea syndrome. | Image Credit: Chinnapong - stock.adobe.com
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies

August 13th 2025

Acute respiratory failure. | Image Credit: Selvi - stock.adobe.com
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment

August 9th 2025

Chronic respiratory disease. | Image Credit: Tipapat - stock.adobe.com
Chronic Respiratory Diseases Linked to Other Noncommunicable Diseases in Vulnerable Countries

August 4th 2025

Continuing Medical Education
View All
August 23rd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 23rd 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
August 23rd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
August 23rd 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology
August 23rd 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology
August 23rd 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology
August 23rd 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

A Timeline of COVID-19 Developments in 2020
January 1st 2021

A Timeline of COVID-19 Developments in 2020

AJMC Staff
Coronavirus disease 2019 (COVID-19) dominated 2020. This is a look back at how the pandemic evolved and progressed through the year, which closed with the arrival of vaccines, but also continued challenges.
Megan Althoff, MD, PhD, University of Colorado
December 30th 2020

Dr Megan Althoff on How, Why the GINA, ERS/ATS Guidelines Differ

One guideline focuses on managing severe asthma and the other begins with recommendations for mild intermittent asthma before increasing based on disease severity, noted Megan Althoff, MD, PhD, University of Colorado.
Top 5 Most-Read Respiratory Stories of 2020
December 29th 2020

Top 5 Most-Read Respiratory Stories of 2020

Skylar Jeremias
The top 5 most-read respiratory stories of 2020 on AJMC.com largely focused on the treatment options and risks associated with idiopathic pulmonary fibrosis (IPF) as well as how mental health and asthma are related.
Nicola Hanania, MD, MS, Baylor College of Medicine
December 23rd 2020

Dr Nicola Hanania: Exacerbation Improvement Is an Important Indicator of Patient Response to Biologics

When evaluating a patient’s response to a biologic for asthma, factors to consider include patient preference, safety, and symptoms, explained Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston, Texas.
What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll
December 23rd 2020

What We’re Reading: US Buys More Pfizer Vaccine; Walmart Sued Over Opioid Crisis; 2020's Deadly Toll

Gianna Melillo
The Trump administration buys 100 million more doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; the Department of Justice files a suit accusing Walmart of fueling the opioid crisis; 2020 set to become deadliest year in US history.
Top 5 Most-Read COVID-19 News of 2020
December 21st 2020

Top 5 Most-Read COVID-19 News of 2020

AJMC Staff
A look at some of our most-read news coverage of the coronavirus disease 2019 (COVID-19) pandemic.
FDA Panel Backs Moderna COVID-19 Vaccine; EUA Expected Next
December 17th 2020

FDA Panel Backs Moderna COVID-19 Vaccine; EUA Expected Next

Allison Inserro
After a daylong meeting, an FDA advisory panel agreed that the second vaccine in the United States to prevent coronavirus disease 2019 (COVID-19) should be put forward for use.
COVID-19 and Health Disparities: An Opportunity to Refocus Resources?
December 14th 2020

COVID-19 and Health Disparities: An Opportunity to Refocus Resources?

Gianna Melillo
Stark realities exposed by the pandemic have led some to advocate for redirecting resources to have the most impact on vulnerable populations.
Anne Reihman, MD, University of Colorado
December 8th 2020

Dr Anne Reihman: Latest Respiratory Research Lacks a Definition for “Adequate Response” in Biologics

Updated guidelines help to address which patients are most appropriate for biologic therapy, noted Anne Reihman, MD, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.
COVID-19 and Health Disparities: Preexisting Factors Impact Exposure, Recovery
December 7th 2020

COVID-19 and Health Disparities: Preexisting Factors Impact Exposure, Recovery

Gianna Melillo
With leading health experts warning of a grim few months ahead as the pandemic continues to rage, and as a vaccine launch grows more imminent, this 3-part series explores the impact of existing health disparities on COVID-19 and some potential solutions.
ecigarette
December 5th 2020

Study Finds Young People Quit or Reduced Vaping Habits During the Pandemic

Skylar Jeremias
A combination of stay-at-home orders and vape and smoke shop closures contributed to why many young adults and people under 21 years old quit or reduced vaping.
What We’re Reading: Record COVID-19 Deaths, Hospitalizations; CDC Revises Quarantine Guidelines; Moderna to Begin Pediatric Vaccine Trial
December 3rd 2020

What We’re Reading: Record COVID-19 Deaths, Hospitalizations; CDC Revises Quarantine Guidelines; Moderna to Begin Pediatric Vaccine Trial

AJMC Staff
The United States reports record numbers of hospitalizations and deaths due to coronavirus disease 2019 (COVID-19); the CDC updates its quarantine recommendations; Moderna will soon start testing its COVID-19 vaccine in children.
Dan Ouellette, MD, MS, FCCP, Henry Ford Hospital
November 29th 2020

Dr Dan Ouellette: The New ERS/ATS Guidelines Provide Information on Biologic Agents

Updating guidelines requires having sufficient information on the elements that are your focus, noted Dan Ouellette, MD, MS, FCCP, senior staff physician and director of the Respiratory Ward at Henry Ford Hospital.
Site Logo
November 24th 2020

Why Even the Threat of a Twindemic Isn’t Swaying the Most Vulnerable: Black Women

Diane M. Ashton, MD, MPH
The fall season was accompanied by an urgent warning from the CDC of an impending “twindemic” of coronavirus disease 2019 and influenza. Despite the warnings, Black women are not lining up for vaccinations.
Megan Althoff, MD, PhD, University of Colorado
November 23rd 2020

Dr Megan Althoff: Updated GINA Guidelines Include Reliever Treatment With an Inhaled Corticosteroid

The 2019/2020 GINA guidelines recommend formoterol to produce better long-term outcomes in patients, noted Megan Althoff, MD, PhD, second-year fellow, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.
What We’re Reading: Efficacy of AstraZeneca Vaccine; FDA Grants EUA for Antibody Cocktail; Assessing Ventilator Usage
November 23rd 2020

What We’re Reading: Efficacy of AstraZeneca Vaccine; FDA Grants EUA for Antibody Cocktail; Assessing Ventilator Usage

AJMC Staff
AstraZeneca announced that its vaccine against coronavirus disease 2019 (COVID-19) could be up to 90% effective; FDA grants emergency use authorization (EUA) for antibody cocktail used against COVID-19; spotlighting shortage of specialists to operate ventilators.
child holding inhaler
November 20th 2020

Self-Management Education, Vaccines, Other Asthma Interventions Could Reduce Health Spending and Utilization

Skylar Jeremias
A study looked at how 4 types of interventions for children with asthma could impact expenditures and utilization among Medicaid programs.
What We’re Reading: Pfizer to Submit EUA Application; WHO Recommends Against Remdesivir; CDC Warns Against Holiday Travel
November 20th 2020

What We’re Reading: Pfizer to Submit EUA Application; WHO Recommends Against Remdesivir; CDC Warns Against Holiday Travel

AJMC Staff
Pfizer will submit an emergency use authorization for their coronavirus disease 2019 (COVID-19) vaccine; WHO panel recommends against remdesivir; CDC urges Americans to stay put during Thanksgiving.
Infant on a nebulizer
November 20th 2020

Implementing Certain Asthma Interventions Could Reduce Health Spending, Utilization

Skylar Jeremias
A study looked at how 4 types of interventions for children with asthma could impact expenditures and utilization among Medicaid programs.
Anthony L. Loschner, MD, Virginia Tech Carilion School of Medicine
November 17th 2020

Dr Anthony Loschner Expounds on the Benefits of AI in Pulmonary Medicine

Artificial intelligence (AI) frees up time for clinicians, noted Anthony L. Loschner, MD, assistant professor and associate program director, Critical Care Fellowship Program, Virginia Tech Carilion School of Medicine.
What We’re Reading: FDA Authorizes Antibody Treatment; ND Attempts to Ease Stress on Hospitals; Fruit Consumption Among Children
November 10th 2020

What We’re Reading: FDA Authorizes Antibody Treatment; ND Attempts to Ease Stress on Hospitals; Fruit Consumption Among Children

AJMC Staff
FDA approves a coronavirus disease 2019 (COVID-19) antibody treatment; North Dakota braces hospitals for surging cases; fruit consumption among children is low.
COVID-19
November 9th 2020

Pfizer Says Vaccine 90% Effective; Biden Team Announces COVID-19 Transition Panel

Allison Inserro
Pfizer said interim data on its coronavirus disease 2019 (COVID-19) vaccine show 90% efficacy; meanwhile, President-elect Joe Biden released the names of his coronavirus advisory board.
pregnant woman in hospital
November 9th 2020

Safe Pregnancy Is Possible for Women With ILD, Study Finds

Skylar Jeremias
In contrast with previous research, a new study suggests that women with interstitial lung disease (ILD) may not need to avoid or terminate pregnancy.
N95 respirator mask
November 5th 2020

Contributor: Made in NC—Reimagining the PPE Supply Chain and Saving Each Other Just in Time

In 2020, there is no item more precious than the N95 respirator mask—a symbol of scarcity due to the systematic failures of coordination, preparation, and policy solutions to respond to the coronavirus disease 2019 pandemic.
flu vaccine vials
November 5th 2020

Study on Flu Vaccination Rates Suggests COVID-19 Immunity May Be Difficult to Achieve

Skylar Jeremias
An analysis of state vaccination rates from the previous flu season suggest that certain communities may face significant challenges in achieving coronavirus disease 2019 (COVID-19) immunity.
Lungs
November 3rd 2020

Complexity of PF-ILD Creates Detection, Treatment Challenges

Skylar Jeremias
Presenters at CHEST 2020 discussed the concept of how patients with interstitial lung disease (ILD) can develop a progressive fibrosis phenotype and how providers can detect and treat these patients.
Maura Abbott, PhD, AOCNP, CPNP, RN, Columbia University School of Nursing
October 30th 2020

Dr Maura Abbott: Talk to Your Patients About Their Vaccine Fears

Spend time with your patients, discussing both the risks and benefits of a potential coronavirus disease 2019 vaccine, emphasized Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.
What We’re Reading: Ransomware Threatens Health Systems; Government Purchases Antibody Drug; Federal COVID-19 Vaccine Plan
October 29th 2020

What We’re Reading: Ransomware Threatens Health Systems; Government Purchases Antibody Drug; Federal COVID-19 Vaccine Plan

AJMC Staff
Ransomware attacks threaten US hospitals; the Trump administration purchases 300,000 doses of an antibody drug; CMS releases coverage plan for COVID-19 vaccine and treatments.
Young boy with inhaler
October 28th 2020

Depression, Anxiety in Pregnancy Linked to Worse Respiratory Health in Children, Study Suggests

Skylar Jeremias
Depression and anxiety in pregnant women may disrupt fetal lung development, leading to an increased incidence of asthma and respiratory symptoms in their children.
Study Backs Decision to Move Forward With Pfizer Vaccine Candidate
October 14th 2020

Study Backs Decision to Move Forward With Pfizer Vaccine Candidate

Skylar Jeremias
Study results from a phase 1 trial looking at 2 RNA-based severe acute respiratory syndrome coronavirus 2 vaccine candidates give further insight into the candidates’ safety profiles.
<1
...
789101112131415
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo